Crane Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Crane Co. on April 28, 2014. The filing reports the results of operations for the quarter ended March 31, 2014, and details the outcomes of the Annual Meeting of Shareholders held on the same date. The report also provides an extensive update on the Company's asbestos liability status, claims activity, and litigation proceedings.
Key Financial Metrics and Asbestos Liability
The filing does not provide specific revenue, profit, or cash flow figures for the quarter; these are referenced in the attached press release (Exhibit 99.1) and financial data supplement (Exhibit 99.2). However, the filing details significant asbestos-related financial data:
- Asbestos Liability: The total estimated asbestos liability was $680 million as of March 31, 2014, down from $894 million recorded as of December 31, 2011. The current portion of this liability is $88 million.
- Insurance Recoveries: An asset of $166 million was recorded as of March 31, 2014, representing probable insurance reimbursements.
- Costs Incurred (Q1 2014): Total pre-tax settlement and defense costs incurred were $20.5 million ($7.7 million for settlements/indemnity and $12.9 million for defense).
- Cash Payments (Q1 2014): Total pre-tax cash payments for settlement and defense costs, net of insurance receipts, were $12.9 million.
- Claims Activity: As of March 31, 2014, there were 50,899 pending asbestos claims. During the quarter, 680 new claims were filed, 303 were settled, and 968 were dismissed.
Material Changes and Corporate Governance
Shareholder Voting Results:
- Director Elections: E. Thayer Bigelow, Philip R. Lochner, Jr., and Max H. Mitchell were elected to the Board of Directors for three-year terms. All received overwhelming support with votes against totaling less than 1.5% of votes cast.
- Auditor Ratification: Shareholders approved the selection of Deloitte & Touche LLP as independent auditors for 2014.
- Executive Compensation: Shareholders approved the compensation of named executive officers.
Asbestos Liability Update:
- The Company determined that no change to its asbestos liability estimate was warranted for the period ended March 31, 2014, as actual experience approximated assumptions.
- The liability estimate covers claims filed or projected to be filed through 2021. The Company does not believe costs beyond 2021 can be reasonably estimated.
- Approximately 80% of the recorded liability is attributable to future claims projected through 2021.
Outlook, Risks, and Contingencies
Significant Litigation: The Company is involved in numerous asbestos-related lawsuits. Key pending or appealed verdicts include:
- Ivo Peraica (NY): A $35 million verdict was reduced to $18 million by the trial court, with a judgment of $10.6 million entered. The Company has appealed.
- Lloyd Garvin (SC): An $11 million compensatory verdict and $11 million exemplary damages were entered. Post-trial motions are pending.
- James Nelson (PA): A previous verdict was vacated by the Pennsylvania Superior Court, and the case was remanded for a new trial. The court granted en banc reargument.
- William Paulus (CA) & Gerald Suttner (NY): Judgments were affirmed on appeal in early 2014. The Company is seeking further review or reargument.
Risks and Uncertainties:
- Estimation of ultimate exposure is subject to significant uncertainties regarding the number of future claims, settlement costs, and defense costs.
- Factors such as legislative changes, case law trends, and the financial viability of insurers could materially alter the liability estimate.
- Cash payments for settlements generally lag the recognition of costs by several months.
Investor Verification Checklist
- Review the attached Earnings Press Release (Exhibit 99.1) and Quarterly Financial Data Supplement (Exhibit 99.2) for specific revenue, net income, and earnings per share figures not detailed in this 8-K text.
- Monitor the status of the Ivo Peraica and Lloyd Garvin appeals, as these represent significant potential liabilities.
- Verify the Company's ability to maintain insurance coverage agreements, as 25% of the liability is estimated to be reimbursable by insurers.
- Track the quarterly trend of new mesothelioma claims versus dismissals, as these are the primary drivers of the liability estimate.
- Confirm the timeline for the en banc reargument in the James Nelson case in Pennsylvania.